The 2-Minute Check Up: Ozempic, Wegovy, Rybelsus: You should know about GLP-1 Agonists

#ozempic #weightloss #weightlossjourney Link to more on Ozempic and #sideeffects:

GLP-1 agonists are a new class of drugs that have been approved by the U.S. Food and Drug Administration (FDA) for weight loss in adults without diabetes. These medications, such as liraglutide and semaglutide, have been found to be effective agents for weight loss in clinical trials. GLP-1 agonists work by stimulating the secretion of insulin and slowing down the release of glucagon, which helps to reduce appetite and promote weight loss.

However, there are some potential risks associated with taking GLP-1 agonists for weight loss. Side effects may include nausea, vomiting, diarrhea, constipation, headache, dizziness, fatigue and abdominal pain. In addition, GLP-1 agonists should not be taken if you have kidney or liver problems or if you are pregnant or breastfeeding.

Overall, GLP-1 agonists can be an effective tool for weight management when used in combination with lifestyle changes such as healthy eating and regular exercise. It is important to speak with your doctor before taking any medication for weight loss to ensure it is right for you.

Host: Dr. Dave Montgomery




Good Doctor TV web series: (see all of Season 1)

YouTube Channels:​​